CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Prophylaxis ; Gross debridement for diseased patientsprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01154855
NCT01154855N/ACompleted
CompareCT.gov

Circulatory Microbial Components and Immune Regulators of Patients With Periodontal Disease and Rheumatoid Arthritis

University of Michigan·observational·Posted Jul 1, 2010·Updated Dec 14, 2015

In Brief

An observational study evaluating Prophylaxis ; Gross debridement for diseased patients for Periodontal Disease. Completed, enrolled 40 participants.

Detailed Summary

The goal of this project is to study the immune activity of certain proteins present in the blood of patients with severe periodontal disease. Periodontal disease (gum disease) is the major cause of tooth loss among adults. Moderate to severe periodontal disease is reported to affect 5-15% of American adults. It begins with an infection of the tissues surrounding the teeth, and leads to a worsening inflammatory response. This study will aid in clarifying the way in which gum disease might affect certain systemic diseases.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeriodontal Disease
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 1, 2010
Enrollment StartJan 1, 2010
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 16.0 years ago

Interventions

Prophylaxis ; Gross debridement for diseased patientsprocedure

1 per patient at 2nd visit lasting approximately 1 hour.